연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1151. Transverse mesocolon invasion in advanced gastric cancer: should we reconsider current T staging?
Kim JW, Kong SH, Kim MA, Kim WH, Lee HJ, Lee KU, Yang HK.
Ann Surg Oncol. 2011 May;18(5):1274-81. Epub 2011 Jan 8.
Link
1150. General perioperative management of gastric cancer patients at high-volume centers.
Ahn HS, Yook JH, Park CH, Park YK, Yu W, Lee MS, Sang-Uk H, Ryu KW, Sohn TS, Kim HH, Choi SH, Noh SH, Hiki N, Sano T, Yang HK.
Gastric Cancer. 2011 Jun;14(2):178-82. Epub 2011 Mar 5.
Link
1149. Comparison of liver function after laparoscopically assisted and open distal gastrectomies for patients with liver disease.
Yoon HM, Yang HK, Lee HJ, Park do J, Kim HH, Lee KU, Ahn HS, Jo JJ.
Surg Endosc. 2011 Jun;25(6):1761-5. Epub 2011 Mar 18.
Link
1148. Dissemination of free cancer cells from the gastric lumen and from perigastric lymphovascular pedicles during radical gastric cancer surgery.
Han TS, Kong SH, Lee HJ, Ahn HS, Hur K, Yu J, Kim WH, Yang HK.
Ann Surg Oncol. 2011 Oct;18(10):2818-25. Epub 2011 Apr 1.
Link
1147. The Value of Palliative Gastrectomy in Gastric Cancer with Distant Metastasis.
Chang YR, Han DS, Kong SH, Lee HJ, Kim SH, Kim WH, Yang HK.
Ann Surg Oncol. 2011 Nov 2. [Epub ahead of print]
Link
1146. Sentinel node biopsy in early gastric cancer: constant exertion for clinical application.
Yang HK.
Ann Surg Oncol. 2012 Feb;19(2):353-4.
Link
1145. Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer.
Nam HJ, Kim HP, Yoon YK, Hur HS, Song SH, Kim MS, Lee GS, Han SW, Im SA, Kim TY, Oh DY, Bang YJ.
Cancer Lett. 2011 Mar 28;302(2):155-65.
Link
1144. Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting.
Lim KH, Kim TY, Lee KH, Han SW, Oh DY, Im SA, Kim TY, Bang YJ.
Cancer Chemother Pharmacol. 2011 Oct;68(4):1017-26. Epub 2011 Feb 17.
Link
1143. Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer.
Park JH, Han SW, Oh DY, Im SA, Jeong SY, Park KJ, Kim TY, Bang YJ, Park JG.
Cancer Chemother Pharmacol. 2011 Oct;68(4):1045-55. Epub 2011 Feb 22.
Link
1142. Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy.
Kim JW, Cha Y, Kim SJ, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ.
Support Care Cancer. 2012 Feb;20(2):395-403. Epub 2011 Mar 11.
Link